# Antipsychotics and Risk of Hyperglycemic Emergencies

> **NCT02582736** · — · COMPLETED · sponsor: **Canadian Network for Observational Drug Effect Studies, CNODES** · enrollment: 725489 (actual)

## Conditions studied

- Psychotic Disorders
- Schizophrenia
- Schizoaffective Disorder
- Bipolar Disorder
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Risperidone
- **DRUG:** atypical antipsychotics (other)
- **DRUG:** typical antipsychotics

## Key facts

- **NCT ID:** NCT02582736
- **Lead sponsor:** Canadian Network for Observational Drug Effect Studies, CNODES
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 725489 (ACTUAL)
- **Last updated:** 2015-10-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582736, "Antipsychotics and Risk of Hyperglycemic Emergencies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02582736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*